L'odyssée vers la survie du cancer du sein métastatique : Le programme de recherche académique AURORA
AURORA, the first international molecular screening programme for metastatic breast cancer, presented at IMPAKT Breast Cancer Conference
Belgian Dr. Martine Piccart has received prestigious international Brinker Award for Scientific Distinction in Clinical Research
Pfizer Awards Breast International Group (BIG) $1 Million Research Grant to Support Non‐Drug Related Breast Cancer Research
New England Journal of Medicine” publishes results of MINDACT clinical trial The 70-gene test (Mammaprint®) can significantly reduce use of chemotherapy among breast cancer patients and has the potential to change clinical practice: 46% of early stage breast cancer patients classified as high-risk by traditional methods can avoid chemotherapy